These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17142142)

  • 1. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus.
    Hui-Bing H; Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K; Kimura H
    Metabolism; 2006 Dec; 55(12):1670-3. PubMed ID: 17142142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
    Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
    Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
    Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
    Al-Sari IE; Al-Quobaili FA; Kabalan YM
    Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
    Habib SS
    Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus.
    Kuzmicki M; Telejko B; Szamatowicz J; Zonenberg A; Nikolajuk A; Kretowski A; Gorska M
    Gynecol Endocrinol; 2009 Apr; 25(4):258-63. PubMed ID: 19408175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity.
    Harsch IA; Bergmann T; Koebnick C; Wiedmann R; Ruderich F; Hahn EG; Konturek PC
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():65-76. PubMed ID: 17443028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes.
    Kadoglou NP; Perrea D; Iliadis F; Angelopoulou N; Liapis C; Alevizos M
    Diabetes Care; 2007 Mar; 30(3):719-21. PubMed ID: 17327348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.
    Herder C; Peltonen M; Koenig W; Kräft I; Müller-Scholze S; Martin S; Lakka T; Ilanne-Parikka P; Eriksson JG; Hämäläinen H; Keinänen-Kiukaanniemi S; Valle TT; Uusitupa M; Lindström J; Kolb H; Tuomilehto J
    Diabetes; 2006 Aug; 55(8):2340-6. PubMed ID: 16873699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus.
    Tesauro M; Rizza S; Iantorno M; Campia U; Cardillo C; Lauro D; Leo R; Turriziani M; Cocciolillo GC; Fusco A; Panza JA; Scuteri A; Federici M; Lauro R; Quon MJ
    Metabolism; 2007 Mar; 56(3):413-9. PubMed ID: 17292732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between resistin and the peripheral neuropathy in type 2 diabetes].
    Wang XH; Wang DQ; Chen SH; Zhang L; Ni YH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1755-7. PubMed ID: 17919381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
    Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
    Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.